FDA panel debates SSRI risk label; APA raises concerns
Year: 2025
Type: article
Source: Mental Health Weekly
DOI: 10.1002/mhw.34565
Author: Valerie A. Canady
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413430397
